Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

In Switzerland, the pharmaceutical sector is of great importance to the economy. Now, large pharmaceutical companies are tilting their diversity targets – in order to cope well with the new US government.

As retailers drop DEI, some Black customers drop them

As retailers like Target and Amazon announce plans to scale back or cut DEI programs in their businesses, Black customers are rethinking where they spend their cash.

Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies acting to avoid penalties from recent U.S. executive orders

Amid Trump's push to abolish DEI, Roche and Novartis adjust hiring initiatives: reports

Amid calls from the U.S. for companies to abandon their DEI efforts, Roche has scrapped its plan to increase the diversity of its leadership.

Roche Scraps Global DEI Leadership Targets on Trump Pressure

(Bloomberg) -- Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump administration is causing companies to back away from DEI policies outside the US.

The Basel-based pharmaceutical company Roche ceases to promote diversity because of a decree by Donald Trump.